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Objective: Both transitory auditory otoemissions (TEOAE) and automated auditory
brainstem responses (AABR) are considered adequate methods for universal hearing
screening. The goal of this study was to compare the results obtained with each
device, applying the same screening procedure.
Materials and methods: From 2001 to 2003, all the newborns in our health area (2454
infants) were evaluated with TEOAE (ILO92, otodynamics) and all those born from
2004 to 2006 (3117) were evaluated with AABR (AccuScreen, Fischer-Zoth). The
population studied included all well newborns and those admitted to neonatal
intensive care units (NICU). The first screening was normally undertaken with well
babies during the first 48 h of life, before hospital discharge. Infants referred from this
first step underwent a second screening after hospital discharge, before they were a
month old.
Results: The results from each study group were compared and analyzed for sig-
nificant differences. TEOAE screening yielded 10.2% fail results from the first screen-
ing step; AABR gave 2.6%. In the second screening step, 2% of the newborns screened
with TEOAEwere referred, whereas 0.32% of those screenedwith AABRwere referred.
These differences are statistically significant.lamanca 16-1A, 47014 Valladolid, Spain. Tel.: +34 983338797.
(J.I. Benito-Orejas).
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Conclusions: Although AABR screening tests involve a slightly higher cost in time and
money than TEOAE, the results obtained compensate this difference. AABR gives
fewer false positives and a lower referral rate; the percent of infants lost during
follow-up is consequently smaller. Therefore, in our environment, universal newborn
auditory screening with AABR is more effective than that with TEOAE.
# 2008 Elsevier Ireland Ltd. All rights reserved.1. Introduction
The goal of newborn auditory screening is to identify
accurately infants with significant hearing impair-
ment in the most rapid and cost-effective way [1].
Unfortunately, the ideal hearing-screening test for
children has yet to be defined [2] and local circum-
stances may make variations necessary. However, a
low false-positive rate is central to the success of a
pre-discharge neonatal hearing-screening program.
Themulti-site study by Norton et al. [3,4], funded by
the National Institute on Deafness and Other Com-
munication Disorders (NIDCD), compared the effec-
tiveness of transient evoked otoacoustic emissions
(TEOAE), distortion product otoacoustic emissions
(DPOAE) and auditory brainstem response (ABR).
They concluded that, taking the visual reinforcement
audiometry (VRA) at 8—12 months corrected age as a
reference, all three methods serve equally well for
newborn hearing screening. None of these methods
measure hearing loss; their goal is objectively eval-
uating adequate hearing function [5]. TEOAE andABR
equipment is constantly evolving and becomingmore
and more automated, with different screening pro-
grams being established in a single phase or several
phases for each method. Determining which of them
is most effective is therefore of great interest.
TEOAE tests are generally thought to be easier to
administer [6] (as scalp electrodes are not required)
and faster [5,7], offering referral rates for the first
screening that range from 6% to 12% [8—12]. These
rates can even increase in preterm infants [13—15]
and newborns younger than 48 h up to 60% [16—19].
AABR tests yield lower first-screening referral rates
(1—4%) [7—9,11,20—22]. If the program is a two-step
screen, the TEOAE referral rate following the sec-
ond test can drop to 6—7% [10,12,23—26]. However,
AABR seems to give fewer false positives, which
range from 1% to 2% after the second screening step
[5,11,18,20,22].
The goal of this study was to compare the results
of a two-step screening process with both TEOAE
and AABR in a similar population of newborns.2. Materials and methods
Our Autonomous Community, Castilla y Leo´n, con-
sists of 9 provinces and has 14 public hospitalsequipped with Maternity Service, including our
Hospital Clı´nico in Valladolid. Political consensus
facilitated the preparation, with the agreement
of the professionals involved, of a set of protocols
approved as the ‘‘Program for Early Detection of and
Integrated Attention to Infant Hearing Loss in Cas-
tilla y Leo´n’’ [27]. The program was implemented in
September 2004, and a hand-held Automatic Audi-
tory Brainstem Response (AABR) device was chosen
for performing the hearing screening, considering
that AABR could be more efficient in our environ-
ment than TEOAE.
Given that screening of all newborns at the Hos-
pital Clı´nico in Valladolid with TEOAE started in
March 2001, it is possible to compare the results
obtained during the first 2 years this protocol was
applied (March 2001—February 2003) against those
from the first 2 years of AABR tests (September
2004—August 2006). Statistical treatment was per-
formed in collaboration with the ‘‘Research Support
Unit’’ at our hospital, using ‘‘EPIDAT’’ statistical
software. Results were compared using chi-squared
test, p < 0.05 being considered significant.
The study was reviewed and approved by the
scientific research committee of the Hospital Clı´nico
in Valladolid.
2.1. Subjects
The population evaluated included all newborns
from the periods indicated (well babies and those
with factors of risk for hearing loss, including new-
borns admitted to neonatal intensive care units
(NICU)). A total of 5571 newborns were available
for screening; 2454 were screened with TEOAE (3.3%
presented risk factors and 13.5% came from NICUs)
and 3117 with AABR (4.6% with risk factors and 14.8%
from NICUs).
In our hospital, well babies are discharged from
24 to 48 h after delivery (except for caesarean
births, where discharge is a few days later). The
initial screening test is performed during this time.
Newborns in NICUs are tested on the day they are
discharged.
The screenings were performed at the mothers’
bedsides under usual postnatal ward conditions,
with the infants in their cots, held in their mothers’
arms, or being nursed at the breast. Informed
consent was received from the mother before the
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ENT Service.
All auditory screenings were done by a nurse in
the Otorhinolaryngology (ENT) Service. (There were
two nurses, who took turns to cover vacation per-
iods.) Auditory screening was not done at the week-
end or on holidays, so if a newborn was discharged
without being screened, an appointment for a few
days later was given. Outpatient babies (infants who
were referred from in-hospital screening and those
who were not accessed or successfully screened
before discharge) were screened in our ENT Service.
The same nurses who began and perfected
their learning curve with TEOAE screening also
had to be trained in AABR testing, given that the
two procedures are different. All the data obtained
in each stage were recorded in a specific computer
database.
Parents were given the results of the hearing
screening prior to discharge in written and verbal
format. They also received a guide with normal
speech and language development indicators, so
they would be able to evaluate and watch over
future language evolution.
2.2. Hearing-screening equipment
Newborns were screened for hearing loss with an
accepted physiologic measure of auditory function
[19,28]: automated auditory brainstem responses
(AABR) or transient evoked otoacoustic emissions
(TEOAE).
TEOAE are elicited by click stimulus delivered by
a probe transducer in the external ear canal. The
emission or ‘‘echo’’ from outer hair cells of the inner
ear is recorded by a microphone in an external ear
probe assembly [8]. TEOAE presence implies integ-
rity of sound transmission through the outer and
middle ear structures and functional integrity of the
outer hair cells.
The equipment used for TEOAE screening was an
ILO92 System (Otodynamics Ltd., Hatfield, UK),
using the Quickscreen program (which reduces test
time and minimizes the effects of low-frequency
noise interference on the detection of TEOAE), and
applying the following validation criteria [12]: Trial Validation: background noise <45 dB sound
pressure level (SPL); a minimum of 50 quiet
sweeps collected; stimulus intensity <86 dB
SPL; stimulus stability 75%. Response Validation: whole wave reproducibility
70%; global signal-to-noise ratio 10 dB SPL;
three additional signal-to-noise ratios met
(1500 Hz  50% or 3 dB, and 2200—3000—
4000 Hz  70% or 6 dB). If a trial was technicallyadequate and these criteria were achieved, the
trial was a ‘‘pass’’.
Auditory brainstem responses imply functional
integrity from the eighth nerve through the auditory
brainstem.
AABR were obtained using an AccuScreen Pro ABR
from Fischer-Zoth, Germany (Madsen-GN Oto-
metrics, Taastrup, Denmark); the device was por-
table and automatic (‘‘pass’’—‘‘refer’’), the result
requiring no interpretation.
To perform AABR, three disposable adhesive gel
electrodes were placed on the infants (the non-
inverting electrode on the upper forehead, the
inverting or referent electrode on the nape of the
neck and a ground electrode on the shoulder).
Impedances accepted, between any two sites, were
always lower than 12 kV. The stimulus consisted of
100 ms clicks of alternating polarity at a frequency
of approximately 55 Hz and an intensity of 35 dB nHL
(hearing level click stimulus referenced to normal
hearing in adults). The clicks were sent through
cushioned coupler earphones attached around the
newborn’s ears, so a probe did not interfere with the
external auditory canal; in addition, the earphones
isolated the newborn from environmental noise.
Data was shown in an 18-ms window post-stimulus,
applying a binomial statistical evaluation algorithm
over the sinuous pattern signal, which offered a
confidence level of >99.5% for the response. The
waveform generated from the brainstem was com-
pared with a template derived from normally hear-
ing infants. The equipment screen showed a graph
that indicated test progress, EEG level and ABR
detection probability. The equipment had a built-
in rejection device for myogenetic, electrical and
environmental noise interference that stopped the
screening when testing conditions would preclude
adequate testing. Based on the results, a ‘‘pass’’ or
‘‘refer’’ was generated after presentation of up to
15,000 stimuli.
2.3. Hearing-screen protocols
The methodology used in the detection of newborn
hearing loss has already been described [12].
Summarizing briefly, it consists of a first screening
step, which is repeated during the first month of
life if the newborns is referred in one or both ears.
When the ‘‘captive period’’ and circumstances
allow, the newborns referred at the initial screen-
ing are rescreened before hospital discharge (the
‘‘pass’’ or ‘‘refer’’ result is still considered as
‘‘initial screening step’’). Infants referred from
the second screening enter formal audiological
assessment.
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were incorporated into two different screening pro-
tocols:
Protocol 1 (March 2001—February 2003): TEOAE screening was performed using an ILO 92
system.
Infants with ‘‘refer’’ results in one or both
ears underwent repeat TEOAE during the first month
of life.
Protocol 2 (September 2004—August 2006): AABR screening was performed using a third-
generation AABR device (AccuScreen ProABR,
Fischer-Zoth).
Infants with ‘‘refer’’ results in one or both ears
underwent repeat AABR during the first month of
life.3. Results
Table 1 shows the comparison of the results obtained
from Protocol 1 (two-step TEOAE screening) and
Protocol 2 (two-step AABR screening). The differ-
ences between both universal hearing-screening
protocols are statistically significant ( p < 0.05) in
all the variables chosen, except for the number of
hearing loss cases diagnosed with each procedure.
The population studied with TEOAE consisted of
2454 newborns during the period fromMarch 2001 to
February 2003. That studied with AABR was 3117Table 1 Results of two-stage newborn hearing screening w
TEOAE
N (infants)
Number of newborns 2482
No-show for first screening 28/2482
Number explored 2454
‘‘Fail’’ first screening 250/2454
No-show for second screening 15/250
‘‘Fail’’ second screening 49/2439
Referred for ENT diagnosis 126/2439
No-show for diagnosis 32/2439
Hearing loss 13/2439
False-positive rates
First screening 237/2454
Second screening 36/2439
Positive hearing loss predictive value
First screening 13/250  100
Second screening 13/49  100
a Only infants born in the hospital.newborns, likewise over 2 years (September 2004 to
August 2006). The increase in the number of infants
in the second period was due not only to a rise in
birth rate, but to the fact that all newborns born in
private health centers with a maternity service
affiliated with our hospital were included in the
screening.
The main results can be summarized as follows:
with TEOAE, 10.2% of the newborns screened were
referred at the first screening stage, in contrast with
2.6% using AABR; 2% of newborns were referred at
the second stage with TEOAE, against 0.32% of those
screened with AABR; 5.2% of newborns screened
with TEOAE (comprising the ‘‘refer’’ (2%) and the
‘‘pass’’ with risk factors (3.2%)) were referred for
ENT diagnosis, while only 0.32% of those screened
with AABR were referred (only the ‘‘refer’’ group).
Based on the V wave thresholds obtained with
AABR, we classified the hearing losses as mild (40—
50 dB nHL), moderate—severe (60—90 dB nHL) and
profound (>90 dB nHL). Through TEOAE hearing
screening, we diagnosed 13 children with perma-
nent hearing loss (5 profound bilateral hearing loss,
3 moderate-severe bilateral, 1 case of moderate-
severe hearing loss in one ear andmild in the other, 2
bilateral mild and 2 unilateral mild hearing loss
cases), of which 54% (7/13) had associated risk
factors for hearing loss. The AABR procedure yielded
six children with permanent hearing loss (one pro-
found bilateral hearing loss case, two bilateral
moderate-severe, one case of moderate—severe
hearing loss in one ear and mild in the other, and
two mild bilateral hearing loss cases), of which 33%
(2/6) had associated risk factors.ith TEOAE and AABR
AABR
% N (infants) %
3129
1.2 12/2858a 0.5
98.8 2846a 99.5
10.2 81/3117 2.6
6 1/81 1.2
2 10/3116 0.32
5.2 10/3116 0.32
1.3 2/3116 0.06
0.54 6/3114 0.19
9.7 75/3117 2.4
1.47 2/3114 0.064
5.2 6/81  100 7.4
26.5 6/8  100 75
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phase was 9.7% with TEOAE and 2.4% with AABR. For
the second stage, the false positive rate was 1.5%
with TEOAE and 0.06% with AABR. The hearing loss
predictive value following the two screening steps
was 26.5% for TEOAE and 75% for AABR.
With TEOAE, 15.3% of the newborns had to be
screened after hospital discharge (outside of the
‘‘captive period’’) because the discharge coincided
with holidays or weekends (not covered by screen-
ing). With AABR, only 6.4% were screened after
hospital discharge because the test could be per-
formed from a few hours following birth. These
differences were the reason why the percent of
newborns not appearing for the first screening after
discharge was 1.13% with TEOAE, in contrast to
0.42% with AABR. Likewise, 6% of newborns who
were referred at the first screening with TEOAE
did not appear for the second screening, in compar-
ison with 1.2% of those not appearing with AABR
screening.
Our results were consistent with those reported
by other researchers [8—26].4. Discussion
Clinical OEA application made it possible to univer-
salize newborn hearing screening because it pro-
vided a simple, quick, effective and non-invasive
method for evaluating cochlear function [29—31].
However, the later ABR and TEOAE automation,
even in the same equipment, made it easier to
evaluate different protocols, where the combina-
tion of one or the other test in one or two stages
achieved the greatest effectiveness [6]. In 1993, the
National Institute of Health (NIH) [32] recom-
mended an initial TEOAE test and, if the result
was ‘‘refer’’, an immediate ABR test as the pre-
ferred screeningmodel [2,7,11,33,34]. Several later
studies [9,18] criticized this model, because higher
referral rates were obtained following the second
test than if only one test with AABR had been
performed. Motives for these results included the
fact that if the AABR is done just after the TEOAE,
the possibilities that the newborn will awake or that
its noise level will increase are greater, thus imped-
ing AABR results [6]. In addition, upon introducing a
probe in the external auditory canal for the TEOAE,
it is easy to drag wax into this canal and obstruct it,
which makes obtaining the AABR more difficult
[6,18,35].
In our hearing-screening protocol, we used two
steps with TEOAE or two steps with AABR [18,20—
22,36]. However, we do feel, in agreement with
Clemens et al. [21,37], that retesting within a shortinterval (i.e., hours) is effective in reducing false
positives. This is logical given that ambient sound
and myogenetic interference are among the most
commonly implicated factors in failed screening. A
change of the infant’s position or activity or a
change in the location of the test will frequently
change the screening result from fail to pass [36,38].
When a newborn failed the test in the maternity
ward, we tried to repeat it, transferring the child to
the ENT Service.
The functional design of the two units used in our
study is current. Although with exceptions, most of
the published data regarding TEOAE have been
obtained through the use of hardware and software
supplied by Otodynamics Ltd. and known as ILO. The
suitability of the AABR equipment used for the test
has been evaluated previously, comparing it with
other third-generation AABR devices [5], and using it
in hearing screening [6].
Tests were performed on well babies in the
maternity ward in their mothers’ rooms. This fre-
quently helped to calm the babies, reducing myo-
genetically caused noise. With AABR, using an ear
probe introduced in the auditory canal offers results
similar to those from coupler earphones [5]; we
prefer coupler earphones because using this system
isolates the newborn from maternity ward noise.
Even accepting that this way of working is a bit more
uncomfortable than transferring the newborn to an
isolated room [5,18,20], it results in more normality,
trust and greater acceptance of the test on the part
of the mothers.
Our results compared hearing screening with
TEOAE and with AABR devices (Table 1). It can be
seen that AABR reduces the rate of false positives
significantly with respect to TEOAE; this reduces
the number of infants that have to be retested
outside the ‘‘captive period’’ and, consequently,
the number who do not appear for retesting
[20,24,31,32,36,39,40].
Generally, the recommended age to begin
screening with TEOAE is 48 h [16—19] because the
presence of debris and vernix in the external meatus
of the newborn is normally significantly reduced by
the second day of life. However, due to the devel-
oping trend of shorter post-delivery hospital stays,
we screen well newborns younger than 48 h. This
increases the number of false positives. The use of
AABR is more time efficient than using TEOAE
because of the significantly increased pass rates
[17,18].
On the other hand, differences in the method of
OAE analysis might account for the difference in the
OAE failure rate [7]. Themore stringent the criteria,
the higher the false-positive rate will be [8]. The
numerical validation indexes of TEOAE response
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by the National Consortium on Newborn Hearing
Screening [41] and those applied by Norton et al.
[3] in their multicenter study. The criteria are fairly
conservative and may refer more neonates with
normal auditory status that if a more liberal pass/
refer system is adopted [8,23,24,35]. However, the
study by Gabbard et al. [17] shows that this differ-
ence is barely significant.
The TEOAE results for failing the first screening
(10.2%) and failing the second screening (2%) are
similar to those of some authors [10,11,19], but
better than those of others [1,16—18,35,38,40].
The percent of infants referred for diagnosis also
drops considerably with AABR; this reduces expense,
anxiety for families [20—22,25,30,37,40,42,43] and
traveling to the diagnosis center, sometimes quite
far from the families’ homes. With TEOAE, infants
who fail the second screening (2%) and those who
pass but have risk factors for hearing loss (3.2%) are
referred for diagnosis. AABR testing, as it evaluates
the functionality of the auditory pathway, also facil-
itates diagnosing cases of auditory neuropathy that
present normal TEOAE results [6,40,44]. This avoids
having to do ABR on infants with risk factors who
‘‘pass’’ the AABR, which is especially important in
centers that depend on another reference center for
performing the ABR. In these cases, the rate of
infants not appearing is very high [36,39], because
(in addition to the problem of traveling) the parents
do not understand the reason why they have to
return, given that their child have ‘‘passed’’ the
TEOAE screening test and apparently present a
normal response to sound.
With marginalized groups or, in our environment,
with the gypsy ethnic group, reducing the number of
infants that have to be retested outside the period
of captivity is very important: first, because they
present a higher incidence of congenital hearing loss
[12], perhaps due to frequent kinship relationships;
and second, because follow-up is especially diffi-
cult, given their marginalized situation. Fifty per-
cent of the infants who failed the second AABR
screening test and the two cases in which the diag-
nostic stage was rejected belonged to these groups.
It is therefore essential to take advantage of the
captivity period as much as possible, and to repeat
the screening test as often as needed to achieve
reliable results. If these infants do not pass the test
in the end, precautions that ensure adequate fol-
low-up will then be taken.
Excluding the two infants mentioned above, we
can say that there was really no false positive in the
remaining eight newborns that did not pass the
second AABR screening. The two infants for whom
a permanent hearing loss was not confirmed pre-sented bilateral serous otitis media during the
screening tests; the cause of their ‘‘fail’’ was thus
the result of a transitory transmission hearing loss
[4,20]. However, mechanical factors in the middle
ear, basilar membrane immaturity or development,
increased myelination in the auditory pathway or
transitory neurological anomalies could be the
cause of false positives with AABR [45,46].
We detected a greater number of hearing loss
cases in the hearing-screening protocol with TEOAE
than in that of AABR. However, given the low pre-
valence of congenital hearing loss and the number
of newborns studied, these differences are not
statistically significant. Nevertheless, these results
could mean that TEOAE, although it is less specific
than AABR, is more sensitive. In previous studies
[13,20,47,48], AABR sensitivity (compared with the
conventional ABR method) oscillated between 90%
and 100%. Accepting the pass/no pass criteria of
35 dB HL [28], some infants will pass the AABR
hearing screening in spite of having a certain degree
of mild permanent hearing loss [28,49]. If we want
to identify all the degrees of hearing loss, we can
lower the AABR screening level, but that would
increase the false positives considerably; in addi-
tion, the costs associated would be so high that the
program, probably, could not survive. Choosing the
criteria that allow infants with ‘‘moderate or
greater hearing loss’’ (>35 dB HL) to be detected,
the false positives and costs can be reduced [50].
ABR is very precise in determining the average
threshold of frequencies at 2000—4000 Hz. How-
ever, its sensitivity is quite low under 1000 Hz and
above 4000 Hz, so false negatives could appear in
hearing losses of unusual configurations [51]. Like-
wise, differences in the size of the external auditory
canal and in the placement and type of earphone
can produce small differences in the stimulus, giving
rise to false negatives in mild hearing losses [49].
The Norton NIH study data [3] would suggest that
OAEs are no more sensitive to mild hearing loss than
ABR [49].
Although TEOAE hearing screening was easier and
more comfortable to perform than that of AABR [5—
7,19,22,26], the differences are becoming less and
less important. As new generations of AABR devices
are developed, administration time is decreasing. It
is true that screening test time varies depending on
the child’s hearing, the presence of partial obstruc-
tions in the external auditory canal or themiddle ear,
and on test conditions. However, the average time
needed to carry out automated ABR testing ranges
from 8 to 15 min [2,5,9,16—18,20,22,26,36,38—40],
and conventional TEOAE tests take from 2 to 13 min
[1,2,9,10,16,17]. We calculate, without exact mea-
surements, that each test took an average of 15 min
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using that of TEOAE.
Studies calculating and comparing the expenses
involved in two-step TEOAE testing with two-
step AABR testing indicate they are analogous
[9,18,38,40]. It is true that disposable supply costs
are practically negligible with TEOAE and approxi-
mately s7 per child with our AABR equipment (the
price of earphones and electrodes) [5]. However,
the lower false positive rates achieved with AABR
and, above all, the lower referral rate with this test
make the total pre- and post-discharge costs for the
two tests similar [9,26]. In our hospital, integrated
in the public health network, the personnel that
administered the screening tests and the schedule
used to perform them was the same in both proce-
dures. Therefore, using AABR, tangible costs
increased by s7 per child, but it is very difficult
to calculate the intangible cost savings (anxiety,
trips back and forth, time lost from work, etc.) that
the lower number of false positives means for the
parents.
As its name indicates, our ‘‘Program for Early
Detection of and Integrated Attention to Infant
Hearing Loss in Castilla y Leo´n’’ contemplates not
only newborn hearing screening, but also the pro-
cedures for diagnosis and multidisciplinary atten-
tion. These are fundamental in a program whose
global goal is taking care of hearing [43]. An essen-
tial part of this attention is the support given by the
primary health care pediatrician [8,29,52]. In the
periodic newborn controls, this professional verifies
the performance of screening tests, plans follow-up
for children with risk factors and evaluates the
appropriate diagnostic and therapeutic attention
in hearing loss, whether confirmed or still to be
confirmed. In addition, given that newborn auditory
screening does not exclude the appearance of late
onset hearing loss [29], pediatricians have the
responsibility of an early diagnosis when faced with
the slightest suspect, on their part or that of family
members, of hearing problems.5. Conclusions
The two-step screening test with AABR does not
involve excessive costs in time or money with
respect to TEOAE testing. We therefore feel it is
the preferred current method for universal newborn
hearing screening in our circumstances, as AABR
testing gives a lower rate of false positives. When
referral rates at hospital discharge decrease, the
number of infants not appearing for the second
stage of screening and the referral rates for diag-
nosis drop. This in turn lowers intangible costsincluding transportation fees, time off during fol-
low-up and parental anxiety from the waiting per-
iod. Furthermore, AABR measurements reflect the
status of the peripheral auditory system and (in
contrast to those of OAE) permit detection of neural
conduction disorders. Finally, it must be remem-
bered that the identification of mild hearing loss in
the neonatal period is not straightforward, that no
screening test performs perfectly and that the
screening program will never identify late-onset
hearing loss. Therefore, regardless of the results
of the infant hearing screening, the parents, med-
ical and nursing personnel, and all other profes-
sionals who have opportunity to observe the child
should pay attention to risk factors and to the
behavioral signs of a possible change in the child’s
hearing status or language development.Acknowledgements
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